Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102

被引：0
|
作者：
Hamauchi, S. [1 ]
Yamazaki, K. [1 ]
Masuishi, T. [2 ]
Kito, Y. [1 ]
Komori, A. [2 ]
Tsushima, T. [1 ]
Todaka, A. [1 ]
Yokota, T. [1 ]
Machida, N. [1 ]
Fukutomi, A. [1 ]
Onozawa, Y. [3 ]
Muro, K. [2 ]
Yasui, H. [1 ]
Mori, K. [4 ]
Taniguchi, H. [2 ]
机构：
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[2] Aichi Canc Ctr Hosp, Div Clin Oncol, Nagoya, Aichi 464, Japan
[3] Shizuoka Canc Ctr, Div Clin Oncol, Shizuoka, Japan
[4] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165P
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [1] Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102
    Hamauchi, Satoshi
    Yamazaki, Kentaro
    Masuishi, Toshiki
    Kito, Yosuke
    Komori, Azusa
    Tsushima, Takahiro
    Narita, Yukiya
    Todaka, Akiko
    Ishihara, Makoto
    Yokota, Tomoya
    Tanaka, Tsutomu
    Machida, Nozomu
    Kadowaki, Shigenori
    Fukutomi, Akira
    Ura, Takashi
    Onozawa, Yusuke
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    Yasui, Hirofumi
    Mori, Keita
    Taniguchi, Hiroya
    [J]. CLINICAL COLORECTAL CANCER, 2017, 16 (01) : 51 - 57
  • [2] TAS-102 in metastatic colorectal cancer
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2018, 19 (01): : E18 - E18
  • [3] Treatment of TAS-102 in patients with metastatic colorectal cancer
    Ota, Takayo
    Tsukuda, Hiroshi
    Hasegawa, Yoshikazu
    Miyatake, Nozomi
    Suzumura, Tomohiro
    Fukuoka, Masahiro
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [4] TAS-102 for metastatic refractory colorectal cancer
    Cleghorn, Sean
    [J]. LANCET ONCOLOGY, 2015, 16 (07): : E314 - E314
  • [5] TAS-102 for the treatment of metastatic colorectal cancer
    Salvatore, Lisa
    Rossini, Daniele
    Moretto, Roberto
    Cremolini, Chiara
    Schirripa, Marta
    Antoniotti, Carlotta
    Marmorino, Federica
    Loupakis, Fotios
    Falcone, Alfredo
    Masi, Gianluca
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1283 - 1292
  • [6] Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer
    Yoshida, Yoichiro
    Sakamoto, Ryohei
    Kajitani, Ryuji
    Munechika, Taro
    Matsumoto, Yoshiko
    Komono, Akira
    Aisu, Naoya
    Daibo, Kojima
    Kiyomi, Fumihiko
    Hasegawa, Suguru
    [J]. ANTICANCER RESEARCH, 2018, 38 (07) : 4367 - 4373
  • [7] Neutropenia as a predictor of efficacy in the treatment of metastatic colorectal cancer with TAS-102 (trifluridine - tipiracil).
    Rodriguez Garces, Maria Yeray
    Senin, Loreto Dominguez
    Urbano, Maria Amor
    Tarazona, Victoria Avino
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15564 - E15564
  • [8] Investigation of TAS-102 in Colorectal Cancer Includes Findings on Neutropenia
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 1 - +
  • [9] Retrospective analysis of TAS-102 for metastatic colorectal cancer
    Aoki, M.
    Shimamoto, F.
    Ikegami, T.
    Yamaguchi, T.
    Terazawa, T.
    Kii, T.
    Goto, M.
    Higuchi, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] TAS-102 plus bevacizumab in metastatic colorectal cancer
    Colloca, Giuseppe A.
    Venturino, Antonella
    [J]. LANCET ONCOLOGY, 2020, 21 (05): : E226 - E226
12345